Amanda Roser, CEO of Ketotic Hypoglycemia International

Amanda Roser becomes CEO of KHI

Ketotic Hypoglycemia International has a new leadership structure. Danielle Drachmann, who founded KHI in 2020, is now President and Founder, and Amanda Roser is our Chief Executive Officer.

Amanda brings more than 18 years of marketing and business leadership experience, much of it in healthcare and medical devices. She first joined KHI as a volunteer heading up marketing.

Her work at KHI is also personal. Amanda’s son, Christopher, developed severe ketotic hypoglycemia as a toddler, and she knows firsthand what families go through when they navigate an underrecognized condition.

As CEO, Amanda will focus on strengthening KHI’s organization, building partnerships, expanding education and supporting research, working alongside Danielle and our international network of medical and scientific advisors.

Meet our team

Danielle welcomed Amanda as CEO on LinkedIn. Read the post on LinkedIn.